Trial
NCT04332107
Azithromycin for COVID-19 Treatment in Outpatients Nationwide
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Thomas M. Lietman
Collaborators
Bill and Melinda Gates Foundation; Pfizer; Stanford University
Condition
COVID-19
Intervention
Azithromycin
Why stopped
Futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-02